drug
hydrocodone bitartrate ER
Marketedupdated 5mo agoby Purdue Pharma LP
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- drugHYDROCODONE BITARTRATE AND ACETAMINOPHEN1,611 co-mentions · 537 sources
- tagApproval1,516 co-mentions · 654 sources
- drugHYDROCODONE BITARTRATE966 co-mentions · 654 sources
- drugHYDROCODONE BITARTRATE AND IBUPROFEN966 co-mentions · 654 sources
- tagSmall Molecule758 co-mentions · 654 sources
- drugAdvil208 co-mentions · 104 sources
- drugMidol208 co-mentions · 104 sources
- drugNuprin208 co-mentions · 104 sources
all catalysts(39)
approval · 39
Nov 6, 2006
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Apr 3, 2007
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Dec 31, 2007
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Apr 23, 2013
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Apr 3, 2015
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Apr 3, 2015
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Jun 2, 2016
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Aug 15, 2018
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Sep 14, 2018
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Sep 18, 2018
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Sep 18, 2018
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Sep 20, 2018
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Sep 21, 2018
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Jul 22, 2019
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Jul 22, 2019
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Oct 11, 2019
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Oct 11, 2019
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Jan 21, 2020
approval
HYDROCODONE BITARTRATE — FDA approval
hydrocodone bitartrate ER
→
Mar 4, 2021
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Mar 4, 2021
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Apr 28, 2021
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Apr 30, 2021
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Sep 2, 2021
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Dec 11, 2023
approval
HYDROCODONE BITARTRATE — FDA approval
hydrocodone bitartrate ER
→
Dec 15, 2023
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Dec 15, 2023
approval
HYDROCODONE BITARTRATE — FDA approval
hydrocodone bitartrate ER
→
Dec 15, 2023
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Dec 15, 2023
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Dec 15, 2023
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Oct 3, 2024
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE — FDA approval
hydrocodone bitartrate ER
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Nov 21, 2024
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Nov 21, 2024
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Sep 26, 2025
approval
HYDROCODONE BITARTRATE — FDA approval
hydrocodone bitartrate ER
→
Dec 22, 2025
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Dec 22, 2025
approval
HYDROCODONE BITARTRATE — FDA approval
hydrocodone bitartrate ER
→
Dec 22, 2025
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
hydrocodone bitartrate ER
→
Trials studying hydrocodone bitartrate ER
Patent cliff
source: FDA Orange Bookfirst barrier falls
Aug 24, 2027
323 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (244)
- Sep 12, 2034method-of-use (U-55)US 10092559
- Sep 12, 2034method-of-use (U-55)US 10092559
- Sep 12, 2034method-of-use (U-55)US 10092559
- Sep 12, 2034method-of-use (U-55)US 10092559
- Sep 12, 2034method-of-use (U-55)US 10092559
- Sep 12, 2034method-of-use (U-55)US 10092559
- Sep 12, 2034formulationUS 9132096
- Sep 12, 2034formulationUS 9132096
- Sep 12, 2034formulationUS 9132096
- Sep 12, 2034formulationUS 9132096
- Sep 12, 2034formulationUS 9132096
- Sep 12, 2034formulationUS 9132096
- Sep 12, 2034method-of-use (U-55)US 9452163
- Sep 12, 2034method-of-use (U-55)US 9452163
- Sep 12, 2034method-of-use (U-55)US 9452163
- Sep 12, 2034method-of-use (U-55)US 9452163
- Sep 12, 2034method-of-use (U-55)US 9452163
- Sep 12, 2034method-of-use (U-55)US 9452163
- Sep 12, 2034method-of-use (U-55)US 9486451
- Sep 12, 2034method-of-use (U-55)US 9486451
- Sep 12, 2034method-of-use (U-55)US 9486451
- Sep 12, 2034method-of-use (U-55)US 9486451
- Sep 12, 2034method-of-use (U-55)US 9486451
- Sep 12, 2034method-of-use (U-55)US 9486451
- Sep 12, 2034formulationUS 9713611
- Sep 12, 2034formulationUS 9713611
- Sep 12, 2034formulationUS 9713611
- Sep 12, 2034formulationUS 9713611
- Sep 12, 2034formulationUS 9713611
- Sep 12, 2034formulationUS 9713611
- Jul 25, 2033method-of-use (U-1810)US 10028946
- Jul 25, 2033method-of-use (U-1810)US 10028946
- Jul 25, 2033method-of-use (U-1810)US 10028946
- Jul 25, 2033method-of-use (U-1810)US 10028946
- Jul 25, 2033method-of-use (U-1810)US 10028946
- Jul 25, 2033method-of-use (U-1810)US 10028946
- Jul 25, 2033formulationUS 10322120
- Jul 25, 2033formulationUS 10322120
- Jul 25, 2033formulationUS 10322120
- Jul 25, 2033formulationUS 10322120
- Jul 25, 2033formulationUS 10322120
- Jul 25, 2033formulationUS 10322120
- Jul 25, 2033method-of-use (U-1810)US 10456393
- Jul 25, 2033method-of-use (U-1810)US 10456393
- Jul 25, 2033method-of-use (U-1810)US 10456393
- Jul 25, 2033method-of-use (U-1810)US 10456393
- Jul 25, 2033method-of-use (U-1810)US 10456393
- Jul 25, 2033method-of-use (U-1810)US 10456393
- Jul 25, 2033method-of-use (U-1810)US 10722511
- Jul 25, 2033method-of-use (U-1810)US 10722511
- Jul 25, 2033method-of-use (U-1810)US 10722511
- Jul 25, 2033method-of-use (U-1810)US 10722511
- Jul 25, 2033method-of-use (U-1810)US 10722511
- Jul 25, 2033method-of-use (U-1810)US 10722511
- Jul 25, 2033method-of-use (U-1810)US 9265760
- Jul 25, 2033method-of-use (U-1810)US 9265760
- Jul 25, 2033method-of-use (U-1810)US 9265760
- Jul 25, 2033method-of-use (U-1810)US 9265760
- Jul 25, 2033method-of-use (U-1810)US 9265760
- Jul 25, 2033method-of-use (U-1810)US 9265760
- Jul 25, 2033method-of-use (U-1810)US 9326982
- Jul 25, 2033method-of-use (U-1810)US 9326982
- Jul 25, 2033method-of-use (U-1810)US 9326982
- Jul 25, 2033method-of-use (U-1810)US 9326982
- Jul 25, 2033method-of-use (U-1810)US 9326982
- Jul 25, 2033method-of-use (U-1810)US 9326982
- Jul 25, 2033method-of-use (U-1810)US 9333201
- Jul 25, 2033method-of-use (U-1810)US 9333201
- Jul 25, 2033method-of-use (U-1810)US 9333201
- Jul 25, 2033method-of-use (U-1810)US 9333201
- Jul 25, 2033method-of-use (U-1810)US 9333201
- Jul 25, 2033method-of-use (U-1810)US 9333201
- Jul 25, 2033method-of-use (U-1810)US 9339499
- Jul 25, 2033method-of-use (U-1810)US 9339499
- Jul 25, 2033method-of-use (U-1810)US 9339499
- Jul 25, 2033method-of-use (U-1810)US 9339499
- Jul 25, 2033method-of-use (U-1810)US 9339499
- Jul 25, 2033method-of-use (U-1810)US 9339499
- Jul 25, 2033method-of-use (U-1810)US 9421200
- Jul 25, 2033method-of-use (U-1810)US 9421200
- Jul 25, 2033method-of-use (U-1810)US 9421200
- Jul 25, 2033method-of-use (U-1810)US 9421200
- Jul 25, 2033method-of-use (U-1810)US 9421200
- Jul 25, 2033method-of-use (U-1810)US 9421200
- Jul 25, 2033method-of-use (U-1810)US 9433619
- Jul 25, 2033method-of-use (U-1810)US 9433619
- Jul 25, 2033method-of-use (U-1810)US 9433619
- Jul 25, 2033method-of-use (U-1810)US 9433619
- Jul 25, 2033method-of-use (U-1810)US 9433619
- Jul 25, 2033method-of-use (U-1810)US 9433619
- Jul 25, 2033method-of-use (U-1810)US 9610286
- Jul 25, 2033method-of-use (U-1810)US 9610286
- Jul 25, 2033method-of-use (U-1810)US 9610286
- Jul 25, 2033method-of-use (U-1810)US 9610286
- Jul 25, 2033method-of-use (U-1810)US 9610286
- Jul 25, 2033method-of-use (U-1810)US 9610286
- Dec 21, 2031formulationUS 8808740
- Dec 21, 2031formulationUS 8808740
- Dec 21, 2031formulationUS 8808740
- Dec 21, 2031formulationUS 8808740
- Dec 21, 2031formulationUS 8808740
- Dec 21, 2031formulationUS 8808740
- Dec 21, 2031formulationUS 8808740
- Dec 21, 2031formulationUS 9572779
- Dec 21, 2031formulationUS 9572779
- Dec 21, 2031formulationUS 9572779
- Dec 21, 2031formulationUS 9572779
- Dec 21, 2031formulationUS 9572779
- Dec 21, 2031formulationUS 9572779
- Dec 21, 2031formulationUS 9572779
- Dec 21, 2031formulationUS 9750703
- Dec 21, 2031formulationUS 9750703
- Dec 21, 2031formulationUS 9750703
- Dec 21, 2031formulationUS 9750703
- Dec 21, 2031formulationUS 9750703
- Dec 21, 2031formulationUS 9750703
- Dec 21, 2031formulationUS 9750703
- Dec 21, 2031formulationUS 9861584
- Dec 21, 2031formulationUS 9861584
- Dec 21, 2031formulationUS 9861584
- Dec 21, 2031formulationUS 9861584
- Dec 21, 2031formulationUS 9861584
- Dec 21, 2031formulationUS 9861584
- Dec 21, 2031formulationUS 9861584
- Dec 21, 2031formulationUS 9872837
- Dec 21, 2031formulationUS 9872837
- Dec 21, 2031formulationUS 9872837
- Dec 21, 2031formulationUS 9872837
- Dec 21, 2031formulationUS 9872837
- Dec 21, 2031formulationUS 9872837
- Dec 21, 2031formulationUS 9872837
- Jul 31, 2029formulationUS 84450182.8y
- Jul 31, 2029formulationUS 84450182.8y
- Jul 31, 2029formulationUS 84450182.8y
- Jul 31, 2029formulationUS 84450182.8y
- Jul 31, 2029formulationUS 84450182.8y
- Sep 13, 2027formulationUS 9216176343d
- Sep 13, 2027formulationUS 9216176343d
- Sep 13, 2027formulationUS 9216176343d
- Sep 13, 2027formulationUS 9216176343d
- Sep 13, 2027formulationUS 9216176343d
- Sep 13, 2027formulationUS 9572803343d
- Sep 13, 2027formulationUS 9572803343d
- Sep 13, 2027formulationUS 9572803343d
- Sep 13, 2027formulationUS 9572803343d
- Sep 13, 2027formulationUS 9572803343d
- Aug 24, 2027formulationUS 11304908323d
- Aug 24, 2027formulationUS 11304908323d
- Aug 24, 2027formulationUS 11304908323d
- Aug 24, 2027formulationUS 11304908323d
- Aug 24, 2027formulationUS 11304908323d
- Aug 24, 2027formulationUS 11304908323d
- Aug 24, 2027formulationUS 11304908323d
- Aug 24, 2027method-of-use (U-1556)US 11304909323d
- Aug 24, 2027method-of-use (U-1556)US 11304909323d
- Aug 24, 2027method-of-use (U-1556)US 11304909323d
- Aug 24, 2027method-of-use (U-1556)US 11304909323d
- Aug 24, 2027method-of-use (U-1556)US 11304909323d
- Aug 24, 2027method-of-use (U-1556)US 11304909323d
- Aug 24, 2027method-of-use (U-1556)US 11304909323d
- Aug 24, 2027formulationUS 9084816323d
- Aug 24, 2027formulationUS 9084816323d
- Aug 24, 2027formulationUS 9084816323d
- Aug 24, 2027formulationUS 9084816323d
- Aug 24, 2027formulationUS 9084816323d
- Aug 24, 2027formulationUS 9084816323d
- Aug 24, 2027formulationUS 9084816323d
- Aug 24, 2027method-of-use (U-1556)US 9095614323d
- Aug 24, 2027method-of-use (U-1556)US 9095614323d
- Aug 24, 2027method-of-use (U-1556)US 9095614323d
- Aug 24, 2027method-of-use (U-1556)US 9095614323d
- Aug 24, 2027method-of-use (U-1556)US 9095614323d
- Aug 24, 2027method-of-use (U-1556)US 9095614323d
- Aug 24, 2027method-of-use (U-1556)US 9095614323d
- Aug 24, 2027formulationUS 9095615323d
- Aug 24, 2027formulationUS 9095615323d
- Aug 24, 2027formulationUS 9095615323d
- Aug 24, 2027formulationUS 9095615323d
- Aug 24, 2027formulationUS 9095615323d
- Aug 24, 2027formulationUS 9095615323d
- Aug 24, 2027formulationUS 9095615323d
- Aug 24, 2027formulationUS 9486412323d
- Aug 24, 2027formulationUS 9486412323d
- Aug 24, 2027formulationUS 9486412323d
- Aug 24, 2027formulationUS 9486412323d
- Aug 24, 2027formulationUS 9486412323d
- Aug 24, 2027formulationUS 9486412323d
- Aug 24, 2027formulationUS 9486412323d
- Aug 24, 2027formulationUS 9486413323d
- Aug 24, 2027formulationUS 9486413323d
- Aug 24, 2027formulationUS 9486413323d
- Aug 24, 2027formulationUS 9486413323d
- Aug 24, 2027formulationUS 9486413323d
- Aug 24, 2027formulationUS 9486413323d
- Aug 24, 2027formulationUS 9486413323d
- Aug 24, 2027formulationUS 9492389323d
- Aug 24, 2027formulationUS 9492389323d
- Aug 24, 2027formulationUS 9492389323d
- Aug 24, 2027formulationUS 9492389323d
- Aug 24, 2027formulationUS 9492389323d
- Aug 24, 2027formulationUS 9492389323d
- Aug 24, 2027formulationUS 9492389323d
- Aug 24, 2027method-of-use (U-1556)US 9492390323d
- Aug 24, 2027method-of-use (U-1556)US 9492390323d
- Aug 24, 2027method-of-use (U-1556)US 9492390323d
- Aug 24, 2027method-of-use (U-1556)US 9492390323d
- Aug 24, 2027method-of-use (U-1556)US 9492390323d
- Aug 24, 2027method-of-use (U-1556)US 9492390323d
- Aug 24, 2027method-of-use (U-1556)US 9492390323d
- Aug 24, 2027method-of-use (U-1556)US 9492391323d
- Aug 24, 2027method-of-use (U-1556)US 9492391323d
- Aug 24, 2027method-of-use (U-1556)US 9492391323d
- Aug 24, 2027method-of-use (U-1556)US 9492391323d
- Aug 24, 2027method-of-use (U-1556)US 9492391323d
- Aug 24, 2027method-of-use (U-1556)US 9492391323d
- Aug 24, 2027method-of-use (U-1556)US 9492391323d
- Aug 24, 2027method-of-use (U-1556)US 9545380323d
- Aug 24, 2027method-of-use (U-1556)US 9545380323d
- Aug 24, 2027method-of-use (U-1556)US 9545380323d
- Aug 24, 2027method-of-use (U-1556)US 9545380323d
- Aug 24, 2027method-of-use (U-1556)US 9545380323d
- Aug 24, 2027method-of-use (U-1556)US 9545380323d
- Aug 24, 2027method-of-use (U-1556)US 9545380323d
- Aug 24, 2027formulationUS 9763933323d
- Aug 24, 2027formulationUS 9763933323d
- Aug 24, 2027formulationUS 9763933323d
- Aug 24, 2027formulationUS 9763933323d
- Aug 24, 2027formulationUS 9763933323d
- Aug 24, 2027formulationUS 9763933323d
- Aug 24, 2027formulationUS 9763933323d
- Aug 24, 2027formulationUS 9770416323d
- Aug 24, 2027formulationUS 9770416323d
- Aug 24, 2027formulationUS 9770416323d
- Aug 24, 2027formulationUS 9770416323d
- Aug 24, 2027formulationUS 9770416323d
- Aug 24, 2027formulationUS 9770416323d
- Aug 24, 2027formulationUS 9770416323d
- Aug 24, 2027formulationUS 9775809323d
- Aug 24, 2027formulationUS 9775809323d
- Aug 24, 2027formulationUS 9775809323d
- Aug 24, 2027formulationUS 9775809323d
- Aug 24, 2027formulationUS 9775809323d
- Aug 24, 2027formulationUS 9775809323d
- Aug 24, 2027formulationUS 9775809323d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that